 
  Search
Filter Results
Displaying 781–790 of 1144 results
- 
        
            National Science Call - 12/4/2019 PowerPoint presentation with audio from the National Science Call, recorded on December 4, 2019 
- 
        
            Nov 27, 2019 Foundation NewsKnown as Pro-EYS, the study will help researchers design clinical trials for potential therapies 
- 
        
            Nov 22, 2019 Beacon StoriesDr. Marciello doesn’t let a Stargardt disease diagnosis get in the way of his twin passions: medicine and baseball. 
- 
        
            Nov 15, 2019 FDA Authorizes Stem Cell Clinical Trial for RP in Los Angeles Research NewsPhase 1/2a human study will evaluate neural progenitors for preserving vision 
- 
        
            Nov 7, 2019 AGTC Announces Development of Stargardt Disease Gene Therapy Research NewsDual-vector delivery system designed to deliver the large ABCA4 gene 
- 
        
            Oct 29, 2019 Iveric Bio’s Therapy Slows Retinal Degeneration in Phase 2b Trial for Dry AMD Research NewsZimura inhibits a complement protein known as C5, a component of the immune system that, when overactive, can cause retinal degeneration. 
- 
        
            Oct 28, 2019 Visionary Artist Elijah Overcomes All Obstacles Beacon StoriesElijah has always had an artist mind, and he hasn’t let his diagnosis with Stargardt disease hold him back from his passion for creating art. 
- 
        
            My Retina Tracker Genetic Testing Program The Foundation Fighting Blindness, in partnership with PreventionGenetics and InformedDNA®, offers an open access, no-cost genetic testing program called the My Retina Tracker® Genetic Testing Program. 
- 
        
            Foundation Fighting Blindness Trustee Call - 10/10/2019 Audio and video of the Board of Trustees call that took place on October 10, 2019. 
- 
        
            Oct 18, 2019 ReNeuron Reports Interim Results for Eight Patients with RP in Phase 2a Trial for Stem Cell Therapy Research NewsThe Foundation funded earlier lab studies that made the clinical trial possible. 
 
             
             
             
            